Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 55111-556

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 55111-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Decitabine injection 50 mg per vial, lyophilized powder for solution, manufactured by Dr. Reddy's Laboratories Limited. The label includes warnings that the product is cytotoxic, instructions for intravenous infusion only, and storage information. The label also displays the NDC 55111-556-10 and barcodes on the panels.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Decitabine, showing its molecular arrangement typical for this pharmaceutical active ingredient.*

FDA Label Image

Vial1 (Vial1)

Label for Decitabine Injection 50 mg per vial, lyophilized powder for intravenous infusion by Dr. Reddy's Laboratories Limited. The label includes dosing instructions, storage conditions, a barcode, and warnings indicating it is a cytotoxic agent requiring dilution before use. The vial is single-dose sterile; unused portion should be discarded.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.